Amendment of rule 24 and 24A of the Drugs Rules, 1945 to omit provisions for issuing duplicate copy of the Import licence and Registration certificate

## Report on the Drugs 6th Amendment Rules, 2021 **1. Executive Summary:** This report analyzes the Drugs 6th Amendment Rules, 2021, which amends the Drugs Rules, 1945. The core purpose of this amendment, as inferred from the text, is to streamline the licensing and registration processes by removing the provision for issuing duplicate copies of licenses and registration certificates in cases where the originals are defaced, damaged, or lost. The key finding is that this change suggests a move towards potentially digital record-keeping or stricter control over license/certificate management, placing a greater burden on licensees/registrants to safeguard their original documents. **2. Introduction:** This report provides an overview of the Drugs 6th Amendment Rules, 2021, based solely on the information provided in the official notification. The purpose is to inform affected industries and stakeholders about the changes introduced to the Drugs Rules, 1945, by this amendment. **3. Policy Overview:** * **Original Policy:** The Drugs Rules, 1945 * **Core Objective(s):** As inferred from the provided text, the amendment aims to modify specific provisions related to the issuance of duplicate licenses and registration certificates. The broader objective of the original Drugs Rules, 1945 (while not explicitly stated here), is likely related to regulating the manufacture, distribution, and sale of drugs and cosmetics to ensure safety and efficacy. **4. Background and Rationale:** This amendment focuses on the removal of the option to obtain duplicate copies of licenses and registration certificates if the originals are defaced, damaged, or lost. The likely rationale behind this change is to improve the integrity and security of the licensing/registration system. The removal suggests the government may be moving away from easily replaceable physical documents, possibly towards a system that prioritizes original document security or digital alternatives. This could be driven by concerns over fraud, administrative burden, or a desire to modernize record-keeping practices. **5. Key Provisions / Changes:** This section details the changes introduced by the Drugs 6th Amendment Rules, 2021: * **Specific Parts of Original Policy Changed:** Rule 24 (subrule 3) and Rule 24A (subrule 7) of the Drugs Rules, 1945. * **New Rule/Provision:** The provision allowing for the issuance of duplicate copies of licenses (under Rule 24(3)) and registration certificates (under Rule 24A(7)) when the original is defaced, damaged, or lost is *removed entirely*. * **Difference/Effect of the Change:** This means that entities operating under the Drugs Rules, 1945 will no longer be able to apply for a duplicate license or registration certificate if the original is compromised. They may potentially need to apply for a new license/registration, depending on further guidance not outlined in the provided text, which could incur additional costs and administrative burden. **6. Target Audience and Stakeholders:** The target audience and stakeholders directly affected by these changes include: * Manufacturers, distributors, and retailers of drugs and cosmetics regulated under the Drugs Rules, 1945. * License holders and those required to have registration certificates under the Drugs Rules, 1945. * Individuals or entities who previously relied on the duplicate license/registration provision in case of loss or damage. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Ministry of Health and Family Welfare, along with the Drugs Technical Advisory Board (mentioned as consulted), are the responsible bodies. * **Timelines or Procedures:** The amendment came into force on the date of its publication in the Official Gazette (November 29, 2021). The text does not specify any transitional procedures for those who may have been in the process of applying for duplicate licenses/certificates prior to this date. It also does not detail the exact process for obtaining a *new* license or registration should the originals be lost or damaged. * **Specific to the Changes:** Companies need to immediately adjust their internal document management procedures to safeguard their original licenses and registration certificates. **8. Expected Outcomes / Impact of Changes:** The likely intended outcomes of these specific changes include: * Increased responsibility for license and registration certificate holders to protect their original documents. * Potentially reduced instances of fraudulent or unauthorized activities related to duplicate licenses/certificates. * Streamlining of the administrative process by removing the need to process duplicate requests. * Potential increased costs or delays for those who lose or damage their original documents as they may need to apply for a completely new license or registration. * In the longer term, potentially a move towards digital licenses/certificates and centralized databases to reduce the risk of loss or damage. **9. Conclusion:** The Drugs 6th Amendment Rules, 2021, represents a significant change to the Drugs Rules, 1945 by removing the provision for duplicate licenses and registration certificates. While this may aim to strengthen the integrity of the regulatory system and streamline administrative processes, it places a greater responsibility on stakeholders to ensure the safekeeping of their original documents. Further clarification from the Ministry of Health and Family Welfare regarding the procedure for handling lost or damaged original documents would be beneficial for the affected industry. This change could signal a move towards more robust digital systems in the future.

Key Entities Referenced